- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Glucagon market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Glucagon size is estimated to be xx million in 2020 from USD 505.9 million in 2019, with a change of XX% between 2019 and 2020. The global Glucagon market size is expected to grow at a CAGR of 5.8% for the next five years.
Market segmentation
Glucagon market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Inject Glucagon
Nasal Glucagon
Market segment by Application can be divided into
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
The key market players for global Glucagon market are listed below:
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Glucagon Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glucagon Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Inject Glucagon
1.2.3 Nasal Glucagon
1.3 Market Analysis by Application
1.3.1 Overview: Global Glucagon Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 Global Glucagon Market Size & Forecast
1.4.1 Global Glucagon Sales in Value (2016-2026))
1.4.2 Global Glucagon Sales in Volume (2016-2026)
1.4.3 Global Glucagon Price by Type (2016-2026) & (USD/MT)
1.5 Global Glucagon Production Capacity Analysis
1.5.1 Global Glucagon Total Production Capacity (2016-2026)
1.5.2 Global Glucagon Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Glucagon Market Drivers
1.6.2 Glucagon Market Restraints
1.6.3 Glucagon Trends Analysis
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Glucagon Product and Services
2.1.4 Novo Nordisk Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Glucagon Product and Services
2.2.4 Eli Lilly Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Fresenius Kabi
2.3.1 Fresenius Kabi Details
2.3.2 Fresenius Kabi Major Business
2.3.3 Fresenius Kabi Glucagon Product and Services
2.3.4 Fresenius Kabi Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Torrent Labs
2.4.1 Torrent Labs Details
2.4.2 Torrent Labs Major Business
2.4.3 Torrent Labs Glucagon Product and Services
2.4.4 Torrent Labs Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Taj Pharmaceuticals
2.5.1 Taj Pharmaceuticals Details
2.5.2 Taj Pharmaceuticals Major Business
2.5.3 Taj Pharmaceuticals Glucagon Product and Services
2.5.4 Taj Pharmaceuticals Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Xeris Pharmaceuticals
2.6.1 Xeris Pharmaceuticals Details
2.6.2 Xeris Pharmaceuticals Major Business
2.6.3 Xeris Pharmaceuticals Glucagon Product and Services
2.6.4 Xeris Pharmaceuticals Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Glucagon Sales by Manufacturer
3.1 Global Glucagon Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Glucagon Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Glucagon
3.4 Market Concentration Rate
3.4.1 Top 3 Glucagon Manufacturer Market Share
3.4.2 Top 6 Glucagon Manufacturer Market Share
3.5 Global Glucagon Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Glucagon Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Glucagon Market Size by Region
4.1.1 Global Glucagon Sales in Volume by Region (2016-2026)
4.1.2 Global Glucagon Revenue by Region (2016-2026)
4.2 North America Glucagon Revenue (2016-2026)
4.3 Europe Glucagon Revenue (2016-2026)
4.4 Asia-Pacific Glucagon Revenue (2016-2026)
4.5 South America Glucagon Revenue (2016-2026)
4.6 Middle East and Africa Glucagon Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Glucagon Sales in Volume by Type (2016-2026)
5.2 Global Glucagon Revenue by Type (2016-2026)
5.3 Global Glucagon Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Glucagon Sales in Volume by Application (2016-2026)
6.2 Global Glucagon Revenue by Application (2016-2026)
6.3 Global Glucagon Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Glucagon Sales by Type (2016-2026)
7.2 North America Glucagon Sales by Application (2016-2026)
7.3 North America Glucagon Market Size by Country
7.3.1 North America Glucagon Sales in Volume by Country (2016-2026)
7.3.2 North America Glucagon Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Glucagon Sales by Type (2016-2026)
8.2 Europe Glucagon Sales by Application (2016-2026)
8.3 Europe Glucagon Market Size by Country
8.3.1 Europe Glucagon Sales in Volume by Country (2016-2026)
8.3.2 Europe Glucagon Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Glucagon Sales by Type (2016-2026)
9.2 Asia-Pacific Glucagon Sales by Application (2016-2026)
9.3 Asia-Pacific Glucagon Market Size by Region
9.3.1 Asia-Pacific Glucagon Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Glucagon Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Glucagon Sales by Type (2016-2026)
10.2 South America Glucagon Sales by Application (2016-2026)
10.3 South America Glucagon Market Size by Country
10.3.1 South America Glucagon Sales in Volume by Country (2016-2026)
10.3.2 South America Glucagon Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Glucagon Sales by Type (2016-2026)
11.2 Middle East & Africa Glucagon Sales by Application (2016-2026)
11.3 Middle East & Africa Glucagon Market Size by Country
11.3.1 Middle East & Africa Glucagon Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Glucagon Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Glucagon Typical Distributors
12.3 Glucagon Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Glucagon Revenue by Type, (USD Million), 2021-2026
Table 2. Global Glucagon Revenue by Application, (USD Million), 2021-2026
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk Glucagon Product and Services
Table 6. Novo Nordisk Glucagon Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly Major Business
Table 9. Eli Lilly Glucagon Product and Services
Table 10. Eli Lilly Glucagon Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 12. Fresenius Kabi Major Business
Table 13. Fresenius Kabi Glucagon Product and Services
Table 14. Fresenius Kabi Glucagon Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Torrent Labs Basic Information, Manufacturing Base and Competitors
Table 16. Torrent Labs Major Business
Table 17. Torrent Labs Glucagon Product and Services
Table 18. Torrent Labs Glucagon Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Taj Pharmaceuticals Major Business
Table 21. Taj Pharmaceuticals Glucagon Product and Services
Table 22. Taj Pharmaceuticals Glucagon Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Xeris Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Xeris Pharmaceuticals Major Business
Table 25. Xeris Pharmaceuticals Glucagon Product and Services
Table 26. Xeris Pharmaceuticals Glucagon Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Global Glucagon Sales by Manufacturer (2019-2021e) & (K MT)
Table 28. Global Glucagon Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 29. Market Position of Manufacturers in Glucagon, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 30. Global Glucagon Production Capacity by Company, (K MT): 2020 VS 2021
Table 31. Head Office and Glucagon Production Site of Key Manufacturer
Table 32. Global Glucagon Sales by Region (2016-2021e) & (K MT)
Table 33. Global Glucagon Sales by Region (2021-2026) & (K MT)
Table 34. Global Glucagon Revenue by Region (2016-2021e) & (USD Million)
Table 35. Global Glucagon Revenue by Region (2021-2026) & (USD Million)
Table 36. Global Glucagon Sales by Type (2016-2021e) & (K MT)
Table 37. Global Glucagon Sales by Type (2021-2026) & (K MT)
Table 38. Global Glucagon Revenue by Type (2016-2021e) & (USD Million)
Table 39. Global Glucagon Revenue by Type (2021-2026) & (USD Million)
Table 40. Global Glucagon Price by Type (2016-2021e) & (USD/MT)
Table 41. Global Glucagon Price by Type (2021-2026) & (USD/MT)
Table 42. Global Glucagon Sales by Application (2016-2021e) & (K MT)
Table 43. Global Glucagon Sales by Application (2021-2026) & (K MT)
Table 44. Global Glucagon Revenue by Application (2016-2021e) & (USD Million)
Table 45. Global Glucagon Revenue by Application (2021-2026) & (USD Million)
Table 46. Global Glucagon Price by Application (2016-2021e) & (USD/MT)
Table 47. Global Glucagon Price by Application (2021-2026) & (USD/MT)
Table 48. North America Glucagon Sales by Country (2016-2021e) & (K MT)
Table 49. North America Glucagon Sales by Country (2021-2026) & (K MT)
Table 50. North America Glucagon Revenue by Country (2016-2021e) & (USD Million)
Table 51. North America Glucagon Revenue by Country (2021-2026) & (USD Million)
Table 52. North America Glucagon Sales by Type (2016-2021e) & (K MT)
Table 53. North America Glucagon Sales by Type (2021-2026) & (K MT)
Table 54. North America Glucagon Sales by Application (2016-2021e) & (K MT)
Table 55. North America Glucagon Sales by Application (2021-2026) & (K MT)
Table 56. Europe Glucagon Sales by Country (2016-2021e) & (K MT)
Table 57. Europe Glucagon Sales by Country (2021-2026) & (K MT)
Table 58. Europe Glucagon Revenue by Country (2016-2021e) & (USD Million)
Table 59. Europe Glucagon Revenue by Country (2021-2026) & (USD Million)
Table 60. Europe Glucagon Sales by Type (2016-2021e) & (K MT)
Table 61. Europe Glucagon Sales by Type (2021-2026) & (K MT)
Table 62. Europe Glucagon Sales by Application (2016-2021e) & (K MT)
Table 63. Europe Glucagon Sales by Application (2021-2026) & (K MT)
Table 64. Asia-Pacific Glucagon Sales by Region (2016-2021e) & (K MT)
Table 65. Asia-Pacific Glucagon Sales by Region (2021-2026) & (K MT)
Table 66. Asia-Pacific Glucagon Revenue by Region (2016-2021e) & (USD Million)
Table 67. Asia-Pacific Glucagon Revenue by Region (2021-2026) & (USD Million)
Table 68. Asia-Pacific Glucagon Sales by Type (2016-2021e) & (K MT)
Table 69. Asia-Pacific Glucagon Sales by Type (2021-2026) & (K MT)
Table 70. Asia-Pacific Glucagon Sales by Application (2016-2021e) & (K MT)
Table 71. Asia-Pacific Glucagon Sales by Application (2021-2026) & (K MT)
Table 72. South America Glucagon Sales by Country (2016-2021e) & (K MT)
Table 73. South America Glucagon Sales by Country (2021-2026) & (K MT)
Table 74. South America Glucagon Revenue by Country (2016-2021e) & (USD Million)
Table 75. South America Glucagon Revenue by Country (2021-2026) & (USD Million)
Table 76. South America Glucagon Sales by Type (2016-2021e) & (K MT)
Table 77. South America Glucagon Sales by Type (2021-2026) & (K MT)
Table 78. South America Glucagon Sales by Application (2016-2021e) & (K MT)
Table 79. South America Glucagon Sales by Application (2021-2026) & (K MT)
Table 80. Middle East & Africa Glucagon Sales by Country (2016-2021e) & (K MT)
Table 81. Middle East & Africa Glucagon Sales by Country (2021-2026) & (K MT)
Table 82. Middle East & Africa Glucagon Revenue by Country (2016-2021e) & (USD Million)
Table 83. Middle East & Africa Glucagon Revenue by Country (2021-2026) & (USD Million)
Table 84. Middle East & Africa Glucagon Sales by Type (2016-2021e) & (K MT)
Table 85. Middle East & Africa Glucagon Sales by Type (2021-2026) & (K MT)
Table 86. Middle East & Africa Glucagon Sales by Application (2016-2021e) & (K MT)
Table 87. Middle East & Africa Glucagon Sales by Application (2021-2026) & (K MT)
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Glucagon Typical Distributors
Table 91. Glucagon Typical Customers
List of Figures
Figure 1. Glucagon Picture
Figure 2. Global Glucagon Sales Market Share by Type in 2020
Figure 3. Inject Glucagon
Figure 4. Nasal Glucagon
Figure 5. Global Glucagon Sales Market Share by Application in 2020
Figure 6. Emergency Kits
Figure 7. General Use
Figure 8. Diagnostic & Motility
Figure 9. Cardiogenic Shock
Figure 10. Others
Figure 11. Global Glucagon Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 12. Global Glucagon Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Glucagon Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Glucagon Sales (2016-2026) & (K MT)
Figure 33. Global Glucagon Production Capacity (2016-2026) & (K MT)
Figure 34. Global Glucagon Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Glucagon Market Drivers
Figure 36. Glucagon Market Restraints
Figure 37. Glucagon Market Trends
Figure 38. Global Glucagon Sales Market Share by Manufacturer in 2020
Figure 39. Global Glucagon Revenue Market Share by Manufacturer in 2020
Figure 40. Glucagon Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Glucagon Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Glucagon Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Glucagon Sales Market Share by Region (2016-2026)
Figure 44. Global Glucagon Revenue Market Share by Region (2016-2026)
Figure 45. North America Glucagon Revenue (2016-2026) & (USD Million)
Figure 46. Europe Glucagon Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Glucagon Revenue (2016-2026) & (USD Million)
Figure 48. South America Glucagon Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Glucagon Revenue (2016-2026) & (USD Million)
Figure 50. Global Glucagon Sales Market Share by Type (2016-2026)
Figure 51. Global Glucagon Revenue Market Share by Type (2016-2026)
Figure 52. Global Glucagon Price by Type (2016-2026) & (USD/MT)
Figure 53. Global Glucagon Sales Market Share by Application (2016-2026)
Figure 54. Global Glucagon Revenue Market Share by Application (2016-2026)
Figure 55. Global Glucagon Price by Application (2016-2026) & (USD/MT)
Figure 56. North America Glucagon Sales Market Share by Country (2016-2026)
Figure 57. North America Glucagon Revenue Market Share by Country (2016-2026)
Figure 58. North America Glucagon Sales Market Share by Type (2016-2026)
Figure 59. North America Glucagon Sales Market Share by Application (2016-2026)
Figure 60. Europe Glucagon Sales Market Share by Country (2016-2026)
Figure 61. Europe Glucagon Revenue Market Share by Country (2016-2026)
Figure 62. Europe Glucagon Sales Market Share by Type (2016-2026)
Figure 63. Europe Glucagon Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Glucagon Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Glucagon Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Glucagon Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Glucagon Sales Market Share by Application (2016-2026)
Figure 68. South America Glucagon Sales Market Share by Country (2016-2026)
Figure 69. South America Glucagon Revenue Market Share by Country (2016-2026)
Figure 70. South America Glucagon Sales Market Share by Type (2016-2026)
Figure 71. South America Glucagon Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Glucagon Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Glucagon Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Glucagon Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Glucagon Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
